Cohort study of off-label use of low-dose IL-2 therapy for systemic autoimmune diseases

Affiliations

• ¹ Department of Internal Medicine, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.
• ² Department of Pharmacy, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.
• ³ Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, and Immunology-Immunopathology-Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
• ⁴ Department of Internal Medicine, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France. [email protected].